Several studies revealed that FLNA expression supports oncogenic diseases in humans such as melanoma, lung and hepatocellular cancer [14,15,16], whereas FLNA protein was decreased in breast cancer. The gene discussed is FLNA; the disease is hepatocellular carcinoma.